Form 8-K - Current report:
SEC Accession No. 0001640334-19-001293
Filing Date
2019-07-03
Accepted
2019-07-03 17:00:11
Documents
2
Period of Report
2019-07-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inmb_8k.htm 8-K 13789
2 PRESS RELEASE inmb_ex991.htm EX-99.1 4197
  Complete submission text file 0001640334-19-001293.txt   19111
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 19942472
SIC: 2836 Biological Products, (No Diagnostic Substances)